Refine by
Heart Transplantation Equipment Supplied In Europe
8 equipment items found
Manufactured by:Menssana Research Inc. based inEdgewater, NEW JERSEY (USA)
The HeartsbreathTM test is a non-invasive breath test for breath biomarkers that predict the probability of grade 3 rejection in heart transplant recipients who received their transplants in the preceding year. It employs a breath collection apparatus (BCA) for collection of volatile organic compounds in breath onto a sorbent trap, as well as for ...
Manufactured by:Berlin Heart GmbH based inBerlin, GERMANY
Patients with Fontan circulatory failure suffer from many Fontan associated end-organ dysfunctions like chronic liver congestion, plastic bronchitis, or protein losing enteropathy and urgently need a donor heart. While these comorbidities indicate a heart transplantation, at the same time they worsen its chance of success. The EXCOR® Venous ...
Manufactured by:Abiomed based inDanvers, MASSACHUSETTS (USA)
The Impella RP heart pump provides temporary, circulatory support for patients who develop right heart failure. It is the only FDA-approved heart pump indicated for patients experiencing acute right heart failure or decompensation following left ventricular assist device implantation, myocardial infraction, heart ...
Manufactured by:Carmat based inImmeuble l’Etendard, FRANCE
Carmat aims to meet a major public health challenge related to cardiovascular diseases, namely heart failure, the leading cause of death in the western world. More specifically, Carmat aims to provide a lasting solution for the treatment of terminal heart failure, a disease for which there are very few effective options today, the main one being ...
Manufactured by:Tonix Pharmaceuticals Holding Corp. based inChatham, NEW JERSEY (USA)
TNX-1500 is a humanized monoclonal antibody (mAb) directed against CD40-ligand, which is also known as CD154, T-BAM, 5c8 antigen, TRAP and gp39. TNX-1500 incorporates the antigen binding fragment (Fab) region of hu5c8 (recombinant monoclonal antibody to CD40-ligand), that has been extensively characterized at the molecular level in complex with the CD40-ligand. TNX-1500 is being studied and ...
Manufactured by:CytoSorbents Corporation based inMonmouth Junction, NEW JERSEY (USA)
he CytoSorb therapy* is based on an extracorporeal blood purification procedure that was shown to effectively reduce excessive levels of inflammatory mediators (see “The Adsorber”). This is intended to alleviate the excess systemic inflammatory response (“cytokine storm”) associated with systemic hyperinflammation or septic shock. Thus, the life-threatening complications ...
Manufactured by:CellProthera based inMulhouse, FRANCE
The unique therapeutic approach proposed by CellProthera is protected by various patents. It requires a simple blood sampling best performed within 2 weeks following a severe AMI. The sampling occurs after a treatment period using GCSF in order to mobilize the patient’s own stem cells into the blood flow. The patient’s blood sample is then forwarded to a local certified Cell Therapy ...
by:tiakis BIOTECH AG based inKiel, GERMANY
Tiprelestat is a pioneering anti-inflammatory and tissue protective drug being developed for the treatment of pulmonary-arterial hypertension, the prevention of serious disease progression of COVID-19 and the prevention of postoperative inflammatory ...